Additionally, some studies have confirmed that ALT and AST are significantly associated with the prognoses of several cancers, such as hepatocellular carcinoma, renal cell carcinoma, colonic, pancreatic, and breast cancer [5,6,7,8,9]. This evidence concerns the gene GOT1 and hepatocellular carcinoma.